Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Research & Development: 2013-2025

Historic Research & Development for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $208,000.

  • Fortress Biotech's Research & Development fell 97.80% to $208,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $22.0 million, marking a year-over-year decrease of 61.28%. This contributed to the annual value of $56.6 million for FY2024, which is 44.34% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Research & Development is $208,000, which was down 97.44% from $8.1 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Research & Development peaked at $43.1 million during Q4 2021, and registered a low of $208,000 during Q3 2025.
  • Its 3-year average for Research & Development is $15.5 million, with a median of $9.8 million in 2023.
  • As far as peak fluctuations go, Fortress Biotech's Research & Development soared by 139.68% in 2021, and later slumped by 97.80% in 2025.
  • Over the past 5 years, Fortress Biotech's Research & Development (Quarterly) stood at $43.1 million in 2021, then dropped by 18.43% to $35.1 million in 2022, then crashed by 72.23% to $9.8 million in 2023, then declined by 0.66% to $9.7 million in 2024, then slumped by 97.80% to $208,000 in 2025.
  • Its last three reported values are $208,000 in Q3 2025, $8.1 million for Q2 2025, and $3.9 million during Q1 2025.